9th - 10th September, Cambridge, UK
More informationJoin the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationCollaboration is always high on the agenda; RQA has several initiatives in the pipeline, with many more under discussion.
An at-a-glance summary of news from around the agency.
The Innovative Licensing and Access Pathway (ILAP) aims to get the most transformative new medicines to patients in the National Health Service (NHS) more quickly.
Latest CTIS newsletter released
New MHRA Blog Post
Inspected March 2024
EMA adopted and draft guidance
New Guidance
This guidance provides information for sponsors, clinical investigators, institutional review boards, contract research organizations, and other interested parties on the use of electronic systems, electronic records, and electronic signatures in clinical investigations of foods, medical products, tobacco products, and new animal drugs.
Registration now open.